NDC 66658-522-01
GAMIFANT 50 mg/2mL
emapalumab-lzsg · INJECTION
Gamifant is an intravenous injection used to treat primary hemophagocytic lymphohistiocytosis, a rare inherited immune disorder where the immune system becomes overactive and damages the body's organs and tissues. It works by blocking interferon gamma, a protein that drives this harmful immune response.
Key Facts
- Brand Name
- GAMIFANT
- Generic Name
- emapalumab-lzsg
- NDC Code (Package)
66658-522-01- NDC Code (Product)
66658-522- Manufacturer
- Swedish Orphan Biovitrum AB (publ)
- Strength
- 50 mg/2mL
- Dosage Form
- INJECTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA761107
- Drug Class
- Interferon gamma Blocker [EPC]
- Marketing Start
- 06/07/2023
Recall History
No Recall HistoryView Full Drug Page
GAMIFANT — All PackagesNot medical advice. This information is for reference only. Always consult your doctor or pharmacist.